Objective:
Evaluate whether early routine post-fibrinolysis angioplasty represents a
reasonable reperfusion option for victims of ST-elevation myocardial infarction
(STEMI), so that these patients could benefit more. Methods:
A total of 936 STEMI patients were enrolled in this study to full Urokinase
within 3 hours (h) followed by stenting within 3 - 12
h (Ultra early routine post-fibrinolysis angioplasty; 472 patients), or primary
stenting within 12 h (primary angioplasty; 464 patints). The primary endpoints
were the reperfusion time within 3 h and the incidence of no-reflow or
slow-reflow. The secondary endpoints were the acute incidence of bleeding, the
extent of myocardial damage, determined by the 6-month left ventricular
function and the 3-year composite incidence of death, reinfarction,
stroke, or revascularization. Results: Ultra early routine post-fibrinolysis
angioplasty significantly increased the percentage of reperfusion treatment
within 3 hours (P < 0.01). The primary angioplasty group resulted in higher
frequency of no-reflow or slow-reflow
(P < 0.01).
Both groups were similar regarding major bleeding (P > 0.05). The 6-month
left ventricular function of early routine post-fibrinolysis angioplasty group
was better than primary angioplasty group. Both groups were similar regarding
reinfarction, stroke or revascularization (P > 0.05), but the incidence of
3-year cumulative death is higher in the primary angioplasty group (P < 0.01).
Conclusion: Ultra early routine post-fibrinolysis angioplasty can significantly
improve effective time window within effective reperfusion treatment percentage,
results in better myocardial perfusion, lower
no-reflow and preserving left ventricular function and the prognosis of
patients with STEMI than primary angioplasty.
Cite this paper
He, X. , Wan, X. , Luo, M. , Wang, H. , Zhong, Q. , Peng, W. and Xue, J. (2014). Ultra Early Routine Post-Fibrinolysis Angioplasty Benefits More Patients with Acute ST-Elevation Myocardial Infarction. Open Access Library Journal, 1, e1109. doi: http://dx.doi.org/10.4236/oalib.1101109.
Van de Werf, F., Bax, J., Betriu, A., et al. (2008) Management of Acute Myocardial Infarction in Patients Presenting with
ST-Segment Elevation. European Heart Journal, 29, 2909-2945. http://dx.doi.org/10.1093/eurheartj/ehn416
Silber, S., Albertsson, P., Aviles, F.F., et al. (2005) Guidelines for Percutaneous Coronary
Interventions. The Task Force for Percutaneous Coronary
Interventions of the European Society of Cardiology. European Heart Journal, 26, 804-847. http://dx.doi.org/10.1093/eurheartj/ehi138
Cantor, W.J., Burnstein, J., Choi, R., et al. (2006) Transfer for Urgent Percutaneous Coronary Intervention Early after
Thrombolysis for ST-Elevation Myocardial Infarction: The TRANSFER-AMI Pilot
Feasibility Study. Canadian Journalof Cardiology, 22, 1121-1126. http://dx.doi.org/10.1016/S0828-282X(06)70948-5
Eagle, K.A., Nallamothu, B.K., Mehta, R.H., et al. (2008) Trends in Acute
Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction from 1999 to
2006: We Are Getting Better but We Have Got a Long Way to Go. European HeartJournal, 29, 609-617. http://dx.doi.org/10.1093/eurheartj/ehn069
Assessment of the Safety and Efficacy of a New
Treatment Strategry with Percutaneous Coronary Intervention (ASSENT- 4 PCI) Investigators
(2006) Primary versus Tenecteplase-Facilitated Percutaneous Coronary Intervention
in Patients with ST Segment Elevation Acute Myocardial Infarction (ASSENT-4
PCI): Randomised Trial. Lancet, 367, 569-578. http://dx.doi.org/10.1016/S0140-6736(06)68147-6
Levine, G.N., Bates, E.R., Blankenship, J.C., et al. (2011) 2011ACCF/AHA/SCAI
Guideline for Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 58, e44-e122. http://dx.doi.org/10.1016/j.jacc.2011.08.007
Di Mario, C., Dudek, D., Piscione, F., et al., CARESS-in-AMI (Combined Abciximab RE-Teplase
Stent Study in Acute Myocardial Infarction)
Investigators (2008) Immediate Angioplasty versus Standard Therapy with Rescue
Angioplasty after Thrombolysis in the Combined Abciximab Reteplase Stent Study
in Acute Myocardial Infarction (CARESS-in- AMI): An Open, Prospective,
Randomised, Multicentre Trial. Lancet, 371, 559-568. http://dx.doi.org/10.1016/S0140-6736(08)60268-8
Zijlstra, F., Patel, A., Jones, M., et al. (2002) Clinical Characteristics and Outcome of Patients with Early (<2 h), Intermediate (2 - 4 h) and Late (>4 h) Presentation Treated by Primary Coronary Angioplasty or Thrombolytic
Therapy for Acute Myocardial Infarction. European Heart Journal, 23, 550-557. http://dx.doi.org/10.1053/euhj.2001.2901
Antoniucci, D., Valenti, R., Migliorini, A., et al. (2002) Relation of
Time to Treatment and Mortality in Patients with Acute Myocardial Infarction
Undergoing Primary Coronary Angioplasty. American
Journal of Cardiology, 89, 1248- 1252. http://dx.doi.org/10.1016/S0002-9149(02)02320-2
Gershlick, A.H., Stephens-Lloyd, A., Hughes, S., et al., REACT Trial Investigators (2005) Rescue Angioplasty
after Failed Thrombolytic Therapy for Acute Myocardial Infarction. New England Journal
of Medicine, 353, 2758-2768. http://dx.doi.org/10.1056/NEJMoa050849
Dudek, D., Dziewierz, A., Rakowski, T., et al. (2006) Angiographic
and Clinical Outcome after Percutaneous Coronary Interventions Following
Combined Fibrinolytic Therapy in Acute Myocardial Infarction. Kardiologia Polska, 64, 239-247.
Dudek, D., Mielecki, W., Zalewski, J., et al. (2006) Influence of Immediate or Delayed Angioplasty after Successful
Thrombolysis on Left Ventricle Remodeling in Cardiac Magnetic Resonance. American Journal of Cardiology, 8, 138. http://dx.doi.org/10.1002/clc.20818
He, X.-Z., Zhou, S.-H., Wan, X.-H., et al. (2011) The Effect of Early and Intensive Statin Therapy on Ventricular Premature
Beat or Nonsustained Ventricular Tachycardia in Patients with Acute Coronary
Syndrome. Clinical Cardiology, 34, 59-63.